Translational Development Acquisition Corp. · NASDAQ:TDAC

Goldman Sachs Group Inc reported a 7.20% stake in Translational Development Acquisition Corp. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 12, 2026

Goldman Sachs Group Inc reported a 7.20% stake in Translational Development Acquisition Corp., 1,056,879 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).

Stake
7.20%
Shares
1,056,879
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.7.20%1,056,879
GOLDMAN SACHS & CO. LLC7.20%1,056,879

Source

View original at SEC

Related